Filed Jan. 3, 2020

Serial No. 88746410

Registered Dec. 8, 2020

Registration No. 6,214,671

Class Public advocacy to promote awareness of the importance of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; lobbying services directed to policy makers, namely, promoting the interests of researchers in the field of regenerative medicine, research institutions in the field of regenerative medicine, patient advocacy groups, and companies developing regenerative medicine products, all in the fields of legislation and regulation; arranging and conducting business partnering forums in the field of regenerative medicine; conducting business development conferences in the field of regenerative medicine, gene therapy, gene editing, cell therapy, tissue-engineering and organ regeneration; all excluding business risk management services in the field of reproductive and primary healthcare; 100; 101; 102; 100; 101; 107

Case Type Service mark